Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Dare Bioscience, Inc. - Common Stock
(NQ:
DARE
)
0.6425
-0.0125 (-1.91%)
Delayed Quote
Updated: 9:49 AM EST, Nov 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dare Bioscience, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 20, 2023
Via
Benzinga
FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional Funding
↗
December 07, 2023
Daré Bioscience Inc (NASDAQ: DARE) announced that the FDA has cleared its investigational new drug (IND) application for DARE-VVA1 as a non-hormonal treatment option for moderate to severe dyspareunia,...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 07, 2023
Via
Benzinga
Earnings Outlook For Dare Bioscience
↗
November 08, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 16, 2023
Via
Benzinga
Earnings Outlook For Dare Bioscience
↗
August 09, 2023
Via
Benzinga
Recap: Dare Bioscience Q1 Earnings
↗
May 11, 2023
Via
Benzinga
Earnings Outlook For Dare Bioscience
↗
May 10, 2023
Via
Benzinga
Earnings Preview: Dare Bioscience
↗
March 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
September 20, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
July 31, 2023
On Monday, 27 stocks hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
July 21, 2023
On Friday, 54 companies hit new 52-week lows.
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Dare Bioscience: Here's What You Need To Know
↗
December 13, 2022
Via
Benzinga
Daré Bioscience's Intravaginal Ring Improves Vasomotor, Vaginal Symptoms Of Menopause
↗
October 17, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
July 17, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
April 03, 2023
We're starting off the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
March 02, 2023
Via
Benzinga
Daré Bioscience Shares Move Higher Intravaginal Ring Shows Promise In Menopause Symptoms
↗
January 09, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
↗
December 01, 2022
Via
Benzinga
Women's Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow
↗
November 14, 2022
Agile Therapeutics Inc. (NASDAQ: AGRX) is on a journey to fulfill the unmet health needs of women with products designed to provide them with contraceptive options.
Via
Benzinga
Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?
October 26, 2022
From Evofem Biosciences Inc.’s (OTCMKTS: EVFM) Phexxi vaginal gel contraceptive to Dare Bioscience Inc.’s (NASDAQ: DARE) Ovaprene, an investigational hormone-free monthly intravaginal contraceptive,...
Via
TheNewswire.com
Can This Company’s Birth Control Patch Disrupt The Contraceptive Market?
October 26, 2022
By Ernest Dela Aglanu, Benzinga
Via
News Direct
Can This Company's Birth Control Patch Disrupt The Contraceptive Market?
↗
October 25, 2022
From Evofem Biosciences Inc.’s (OTCMKTS: EVFM) Phexxi vaginal gel contraceptive to Dare Bioscience Inc.’s (NASDAQ: DARE) Ovaprene, an investigational hormone-free monthly intravaginal contraceptive,...
Via
Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
↗
August 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Outlook For Dare Bioscience
↗
August 08, 2022
Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that Dare...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
July 25, 2022
Gainers
Via
Benzinga
President Biden Mulls Health Emergency For Abortion Access: Report
↗
July 11, 2022
Via
Benzinga
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
↗
July 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 07, 2022
Gainers
Via
Benzinga
EVFM Stock: Contraception Maker Evofem Biosciences Doubles After Roe Decision
↗
June 27, 2022
Evofem Biosciences is in the spotlight following the overturning of Roe v. Wade. Here's why EVFM stock is a name to watch.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
